Book Description:
In the midst of national concern over illicit drug use and abuse, prescription drug abuse has been identified as the United States' fastest growing drug problem. Nearly all prescription drugs involved in overdoses are originally prescribed by a physician (rather than, for example, being stolen from pharmacies). Thus, attention has been directed toward preventing the diversion of prescription drugs after the prescriptions are dispensed. Prescription drug monitoring programs (PDMPs) maintain statewide electronic databases of prescriptions dispensed for controlled substances. This book provides an overview of PDMPs with a focus on supporting access to legitimate medical use of controlled substances; identifying or preventing drug abuse and diversion; facilitating the identification of prescription drug-addicted individuals and enabling intervention and treatment; and outlining and educating the public on drug use and abuse trends to inform public health initiatives. (Imprint: Novinka)

We’ve partnered with Copyright Clearance Center to make it easy for you to request permissions to reuse Nova content.
For more information, click here or click the "Get Permission" button below to link directly to this book on Copyright Clearance Center's website.

Table of Contents:
Preface pp. i-vii

Prescription Drug Monitoring Programs
(Kristin M. Finklea, Erin Bagalman, Lisa N. Sacco, CRS) pp. 1-30

Statement of John L. Eadie, Director, Prescription Drug Monitoring Program Center of Excellence, Brandeis University. Hearing on "Prescription Drug Abuse" pp. 31-42

Prescription Drug Data: HHS has Issued Health Privacy and Security Regulations but Needs to Improve Guidance and Oversight pp. 43-72
(GAO)

Index pp. 73-78